NIH-funded research R01 grant

Understanding how cellular dysfunction contributes to Alzheimer's disease

Official title: Characterization of AD-related endolysosomal dysfunction in human neural cells

Funded at University of Washington · NIH-11079457 · Data updated 2026-11-12

This study is looking at how certain genetic changes related to Alzheimer's disease affect brain cells, using special cells from patients, to help understand the disease better and find new ways to treat it.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Washington
NIH-funded
Lab location1 site (Seattle, United States)
Project startMay 1, 2024
Project endApril 30, 2029
Funding year2025
Award (this year)$815,882
NIH project number5R01AG080585-02
Project IDNIH-11079457 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with a genetic predisposition to Alzheimer's disease, particularly those with variants in the SORL1 gene.

Less likely to help

Patients without a genetic risk for Alzheimer's disease or those with advanced stages of the disease may not benefit from this research.

What this research studies

This research investigates the role of endo-lysosomal dysfunction in Alzheimer's disease by using human induced pluripotent stem cells (hiPSCs) derived from patients. The team will focus on how genetic variations in the SORL1 gene, which is linked to Alzheimer's risk, affect the function of neurons and microglia. By studying these cells, researchers aim to uncover the mechanisms behind cellular dysfunction in the brain and explore potential therapeutic pathways. This approach combines genetics and cell biology to provide insights into the disease's progression.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for preventing or treating Alzheimer's disease.

How similar studies have gone: Previous research has shown promising results in understanding the genetic factors contributing to Alzheimer's disease, making this approach both relevant and potentially impactful.

Where this research is happening

  • University of Washington
    Seattle, United States
    Active

Researchers

  • Principal investigator: Young, Jessica Elaine — University of Washington
  • Study coordinator: Young, Jessica Elaine

Related research

Other NIH-funded projects on the same topics.

  • Making genetic testing more accessible to the public

    This study is all about making it easier for people at risk of certain cancers, like breast, ovarian, and colon cancers, to get genetic testing, so we can find out what helps them access these important services and understand how they can benefit from them.

    NIH research University of Washington · Seattle, United States · NIH-9845571

  • Breast cancer diagnosis in low-resource settings using millifluidics and fast digital imaging in Ghana

    A new project will test a fast, low-cost way to diagnose breast cancer at the point of care in Ghana using small-batch fluidics and direct digital imaging.

    NIH research University of Washington · Seattle, United States · NIH-11645064

  • Binaural Hearing and Speech in Noise in Children

    This project explores how children hear speech in noisy classrooms using how the two ears work together to see if binaural processing differences explain why some kids struggle more than others.

    NIH research University of Washington · Seattle, United States · NIH-11631484

  • Neural circuits that control pain aversion in the brain

    Researchers are exploring how a specific brain area helps people feel and avoid pain, with potential to lead to better pain treatments.

    NIH research University of Washington · Seattle, United States · NIH-11629742

  • United World Antiviral Research Network (UWARN)

    A collaborative, international effort is testing new virus surveillance and evolution ideas to help people living with HIV and communities in LMICs stay safer from current and emerging viruses.

    NIH research University of Washington · Seattle, United States · NIH-11627864

  • HF endotypes in heart failure using ethical multi-modal AI and molecular data

    A patient-friendly project that uses advanced AI and multiple kinds of health data to identify distinct heart failure subtypes that could guide personalized care.

    NIH research University of Washington · Seattle, United States · NIH-11621806

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.